CN104491060A - Tradtional Chinese medicine for preventing relapse of glioma - Google Patents
Tradtional Chinese medicine for preventing relapse of glioma Download PDFInfo
- Publication number
- CN104491060A CN104491060A CN201410728716.3A CN201410728716A CN104491060A CN 104491060 A CN104491060 A CN 104491060A CN 201410728716 A CN201410728716 A CN 201410728716A CN 104491060 A CN104491060 A CN 104491060A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- glioma
- portions
- cerebral glioma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
Abstract
The invention discloses a Chinese medicine for preventing relapse of glioma, and relates to a tradtional Chinese medicine. The tradtional Chinese medicine overcomes the defect of relapse of glioma postoperative patients, and can promote quicker recovery of patients and delay or eliminate great harm of relapse of glioma to patients, families and the society if early application. The tradtional Chinese medicine for preventing relapse of glioma comprises the following components in parts by weight: 30 parts of agrimonia pilosa, 30 parts of astragalus root, 30 parts of angelica, 25 parts of algae, 25 parts of kelp, 20 parts of pseudo-ginseng, 15 parts of taxus chinensis, 15 parts of peach seeds, 15 parts of safflower, 15 parts of honeysuckle, 15 parts of forsythia, 15 parts of dandelion, 10 parts of ganoderma lucidum and 10 parts of honey-fried licorice root. The tradtional Chinese medicine for preventing relapse of glioma does not contain toxic Chinese medicinal components, does not have toxic or side effect, has low cost and can be used for treating various glioma postoperative patients (or glioma patients who can not be treated by operations), the treatment course is 20-30 days, the treatment effect is good, the effective rate reaches 100%, and the cure rate reaches over 60%.
Description
Technical field
The present invention relates to a kind of Chinese medicine.
Background technology
Cerebral glioma (cerebral glioma) accounts for 46% of intracranial tumor.World Health Organization (WHO) announces and presses the ranking of mortality rate order for 1998, and glioblastoma is the 2nd cause of death of less than 34 years old tumor patient, is the 3rd cause of death of 35 ~ 54 years old patient.The low person's poor growth of glioma grade malignancy, the course of disease is longer, certainly occurs symptom to consultation time average 2 years, and pernicious person's tumor bulk-growth is fast, and the course of disease is short, certainly occurring that symptom is to most within 3 months time medical.Along with the progress of science and technology, cerebral glioma can take excision, the multiple means such as radiotherapy, chemotherapy, but cerebral glioma recurrence still remains high, and causing to Patients with gliomas family and entire society greatly affects.
Summary of the invention
The object of the invention is the problem recurred very soon to solve cerebral glioma postoperative patient, the postoperative administration as early as possible of cerebral glioma, intervenes in early days, to eliminate or to delay the recurrence of cerebral glioma.The Chinese medicine of prevention brain colloid recurrence comprises 30 parts of Herba Agrimoniaes, 30 parts of Radixs Astragali, 30 parts of Radix Angelicae Sinensis, 25 portions of Sargassums, 25 parts of Thallus Laminariae (Thallus Eckloniae)s, 20 portions of Radix Notoginseng, 15 portions of Ramulus et folium taxi cuspidatae, 15 parts of Semen Persicaes, 15 parts of Flos Carthamis, 15 portions of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Herba Taraxacis, 10 parts of Ganodermas, 10 parts of Radix Glycyrrhizae Preparatas by ratio of weight and the number of copies.The Chinese medicine avirulence Chinese medicine ingredients that the present invention prevents cerebral glioma to recur, has no side effect, and draws materials easily, with low cost, easy to prepare, instant effect.The course for the treatment of is about 20-30 days, good effect, and effective percentage reaches 100%, and cure rate reaches more than 60%.
Chinese crude drug Herba Agrimoniae of the present invention---function cures mainly: astringing to arrest bleeding, tonify deficiency, removing food stagnancy, dysentery relieving, parasite killing, removing toxic substances and promoting subsidence of swelling.Be used for treating the multiple hemorrhages such as spitting of blood, haematemesis, have loose bowels, dysentery, furuncle carbuncle, the parasitosis such as ascarid, cestode and de-power impairment caused by overstrain, spiritlessness and weakness, the cards such as shallow complexion.
The Radix Astragali---function cures mainly: benefiting QI for strengthening the superficies, and arresting sweating takes off admittedly, holder skin ulcer granulation promoting, inducing diuresis to remove edema.Be used for the treatment of the deficiency of vital energy weak, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst, chronic nephritis, albuminuria, diabetes etc.
Radix Angelicae Sinensis---function cures mainly: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.For blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.
Sargassum---function cures mainly: softening the hard mass, expectorant, and diuretic expels the heat-evil.Control scrofula, goiter, gather, edema, beriberi, painful and swollen testis.
Thallus Laminariae (Thallus Eckloniae)---function cures mainly: hard masses softening and resolving, expectorant, diuretic.For goiter, scrofula, painful and swollen testis, phlegm retention edema.
Radix Notoginseng---function cures mainly: hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Control haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, retention of lochia, fall and flutter blood stasis, traumatic hemorrhage, carbuncle pain.
Ramulus et folium taxi cuspidatae---function cures mainly: inducing diuresis to remove edema, cancer preventing and treating.Treatment leukemia, nephritis, diabetes and POLYCYSTIC KIDNEY DISEASE and various cancer.
Semen Persicae---function cures mainly: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma.For amenorrhea, dysmenorrhea , WEIJIA mass in the abdomen, injury from falling down, dryness of the intestine constipation.
Flos Carthami---function cures mainly: latus rectum of invigorating blood circulation, eliminating stasis to stop pain.Cure mainly puerperal blood faints, the stagnant stomachache of the stasis of blood, obstruction of qi in the chest and cardialgia, accumulation of blood, traumatic injury congestive edema, arthralgia, paralysis due to windstroke, macular eruption being dark-purple, dysmenorrhea, amenorrhea.
Flos Lonicerae---function cures mainly: heat-clearing and toxic substances removing, wind-heat dissipating.For carbuncle furuncle, sore throat, erysipelas, warm blood fulminant dysentery, anemopyretic cold, epidemic febrile disease is generated heat.
Fructus Forsythiae---function cures mainly: heat-clearing and toxic substances removing, mass dissipating and swelling eliminating.Cure mainly calentura, anemopyretic cold, heating, vexed, laryngopharynx swelling and pain, macule, erysipelas, scrofula, carbuncle pyogenic infections from tumour or sore, acute nephritis, pyretic stranguria.
Herba Taraxaci---function cures mainly: heat-clearing and toxic substances removing; Eliminating carbuncle eliminating stagnation cures mainly: acute mastitis; Lung abscess; Intestinal carbuncle; Mumps; Furuncle carbuncle toxin; Conjunctival congestion and swelling pain; Cold, fever; Cough; Laryngopharynx swelling and pain; Stomach-fire; Intestinal is scorching; Dysentery; Hepatitis; Gallbladder frightens inflammation; Urinary tract infection; Snake bite and insect sting.
Ganoderma---function cures mainly: strengthening by means of tonics. for brain-strengthening, and antiinflammatory, diuresis, kidney tonifying.Cure mainly asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.
Radix Glycyrrhizae Preparata---function cures mainly: spleen reinforcing stomach function regulating, Yiqi and vein recovery.For weakness of the spleen and stomach, fatigue and weakness, severe palpitation, irregularly intermittent and regularly intermittent pulse.
Detailed description of the invention
Detailed description of the invention one: the Chinese medicine of present embodiment prevention cerebral glioma recurrence is made up of 30 parts of Herba Agrimoniaes, 30 parts of Radixs Astragali, 30 parts of Radix Angelicae Sinensis, 25 parts of Sargassums, 25 parts of Thallus Laminariae (Thallus Eckloniae)s, 20 parts of Radix Notoginseng, 15 parts of Ramulus et folium taxi cuspidatae, 15 parts of Semen Persicaes, 15 parts of Flos Carthamis, 15 parts of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Herba Taraxacis, 10 parts of Ganodermas, 10 parts of Radix Glycyrrhizae Preparatas by ratio of weight and the number of copies.
The Chinese medicine of the prevention cerebral glioma recurrence of present embodiment is with hard masses softening and resolving, and expectorant, diuretic, heat-clearing and toxic substances removing, benefiting QI for activating blood circulation is that theoretical basis carries out group medicine.The prepared slices of Chinese crude drugs in present embodiment can be ground into and be less than after 100 object powder mix homogeneously by ratio of weight and the number of copies, directly make capsule.
Usage and dosage: the cerebral glioma postoperative patient state of an illness comparatively steadily after (or finding to be not suitable for surgical patient) administration immediately, take medicine every day 3 times, each drug administration composition 10 grams, contraindication in pregnancy, period in a medicine can not be taken food seafood, raw food, the irritable food such as pungent.
Table 1 is the clinical pharrnacokinetics report of present embodiment prevention cerebral glioma postoperative recurrence, wherein cures: symptom or the positive sign of objective determination disappear (CT or MRI); Effective: symptom is obviously improved, leave partial symptoms or the obvious life cycle extending patient; Invalid: symptom and objective sign are without improvement or slightly improve.
Table 1 be 120 example ages 26-63 year cerebral glioma postoperative (or find can not surgical patient) apply the treatment situation of this Chinese medicine, condition-inference accepts and believe the report that regular hospital provides.
Table 1 (unit: people)
Take the Chinese medicine of present embodiment prevention cerebral glioma postoperative recurrence and coordinate acupuncture, the qigong, psychotherapy, therapeutic effect is more remarkable, and cure rate is higher than 60%.
Chinese medicine present embodiment after healing of prevention cerebral glioma postoperative recurrence also will continue to take medicine 7-10 days with consolidate curative effect, and has regular physical checkups.
detailed description of the invention two: the difference of present embodiment and detailed description of the invention one is: prevent the Chinese medicine of cerebral glioma postoperative recurrence to be made up of 30 parts of Herba Agrimoniaes, 30 parts of Radixs Astragali, 30 parts of Radix Angelicae Sinensis, 25 parts of Sargassums, 25 parts of Thallus Laminariae (Thallus Eckloniae)s, 20 parts of Radix Notoginseng, 15 parts of Ramulus et folium taxi cuspidatae, 15 parts of Semen Persicaes, 15 parts of Flos Carthamis, 15 parts of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Herba Taraxacis, 10 parts of Ganodermas, 10 parts of Eupolyphaga Seu Steleophagas, 10 parts of Squama Maniss, 10 parts of Hirudos, 10 parts of Concha Ostreaes, 10 parts of Radix Glycyrrhizae Preparatas by ratio of weight and the number of copies.
Increase in present embodiment Chinese crude drug Eupolyphaga Seu Steleophaga---function cures mainly: removing blood stasis; Reunion of fractured tendons and bones.Cure mainly: blood stasis amenorrhea , mass in the abdomen amasss block; Traumatic injury congestive edema; Muscles and bones is fractured; Swollen and rigid tongue congenital deformity of the tongue.
Squama Manis---function cures mainly: the routed carbuncle of detumescence, searches wind active, stimulating milk secretion of stimulating the menstrual flow.Control carbuncle skin ulcer to swell, anemofrigid-damp arthralgia, amenorrhea, galactostasis, external is stopped blooding.
Hirudo---function cures mainly: removing blood stasis, and removing blood stasis stimulates the menstrual flow.Control blood-retention , mass in the abdomen, gather, women's amenorrhea, blood stasis becomes consumptive disease, injury from falling down, and order is pain also, nebula.
Concha Ostreae---function cures mainly: yin fluid astringing, YANG hyperactivity suppressing, hidroschesis, and arresting seminal emission reduces phlegm, softening the hard mass.Control infantile convulsion, dizzy, spontaneous perspiration, night sweat, seminal emission, stranguria with turbid discharge, metrorrhagia, leukorrhagia, scrofula, goiter.For insomnia of palpitating with fear, vertigo and tinnitus, tuberculous lymphadenitis, abdominal mass mass in the abdomen, spontaneous sweating, seminal emission metrorrhagia and leukorrhagia, stomachache pantothenic acid.
Table 2 is clinical pharrnacokinetics reports that present embodiment prevention occurs in the postoperative prevention of recurrence of Interhemispheric cerebral glioma, and the therapeutic effect that present embodiment prevention occurs in Interhemispheric cerebral glioma is remarkable.Cure rate is higher than 64%.
Table 2 (unit: people)
Detailed description of the invention three: the difference of present embodiment and detailed description of the invention one is: prevent the Chinese medicine of cerebral glioma postoperative recurrence to be made up of 30 parts of Herba Agrimoniaes, 30 portions of Radixs Astragali, 30 portions of Radix Angelicae Sinensis, 25 portions of Sargassums, 25 portions of Thallus Laminariae (Thallus Eckloniae)s, 20 portions of Radix Notoginseng, 15 portions of Ramulus et folium taxi cuspidatae, 15 portions of Semen Persicaes, 15 portions of Flos Carthamis, 15 portions of Flos Loniceraes, 15 portions of Fructus Forsythiaes, 15 portions of Herba Taraxacis, 15 portions of Radix Panacis Quinquefoliis, 10 portions of Ganodermas, 10 portions of Radix Glycyrrhizae Preparatas, 3 portions of Bufo siccuss, 3 portions of Scorpios by ratio of weight and the number of copies.
Increase in present embodiment Chinese crude drug Radix Panacis Quinquefolii---function cures mainly: lung benefiting is cloudy, clear asthenic fire, promoting the production of body fluid to quench thirst.Lose for deficiency of vital energy the moon, interior-heat, cough with asthma expectorant blood, deficiency-heat is tired of tired, quenches one's thirst, dryness of the mouth and throat.
Bufo siccus---function cures mainly: heat-clearing and toxic substances removing, diuretic relieving distension.Control carbuncle, toxic swelling, scrofula, tumor, infantile malnutrition abdominal distention, chronic tracheitis.
Scorpio---function cures mainly: dispel the wind, relieving convulsion, dredging collateral, removing toxic substances.Control convulsion with spasms, epilepsy, apoplexy, hemiplegia, facial hemiparalysis, migraine, rheumatic arthralgia, tetanus, tuberculous lymphadenitis, rubella skin ulcer swells.
Table 3 is present embodiments for the postoperative clinical pharmacy report of the cerebral glioma that prevents to occur in cerebellum, and present embodiment prevention occurs in the cerebral glioma postoperative patient Be very effective of hemisphaerium cerebelli, and cure rate is higher than 60%.
table 3 (unit: people)
Occur in the patient that the cerebral glioma of hemisphaerium cerebelli is postoperative | Cure | Effectively | Invalid |
65 | 40 | 25 | 0 |
Claims (3)
1. prevent the Chinese medicine of cerebral glioma recurrence, it is characterized in that preventing the Chinese medicine of cerebral glioma recurrence to comprise 30 parts of Herba Agrimoniaes, 30 parts of Radixs Astragali, 30 parts of Radix Angelicae Sinensis, 25 portions of Sargassums, 25 parts of Thallus Laminariae (Thallus Eckloniae)s, 20 portions of Radix Notoginseng, 15 portions of Ramulus et folium taxi cuspidatae, 15 parts of Semen Persicaes, 15 parts of Flos Carthamis, 15 portions of Flos Loniceraes, 15 parts of Fructus Forsythiaes, 15 parts of Herba Taraxacis, 10 parts of Ganodermas, 10 parts of Radix Glycyrrhizae Preparatas by ratio of weight and the number of copies.
2. the Chinese medicine of prevention cerebral glioma recurrence according to claim 1, is characterized in that preventing the Chinese medicine of cerebral glioma recurrence also to comprise 10 parts of Eupolyphaga Seu Steleophagas, 10 parts of Squama Maniss, 10 portions of Hirudos, 10 portions of Concha Ostreaes by ratio of weight and the number of copies.
3. the Chinese medicine of prevention cerebral glioma recurrence according to claim 1, is characterized in that preventing the Chinese medicine of cerebral glioma recurrence also to comprise 15 parts of Radix Panacis Quinquefoliis, 3 portions of Bufo siccuss, 3 portions of Scorpios by portion rate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728716.3A CN104491060A (en) | 2014-12-05 | 2014-12-05 | Tradtional Chinese medicine for preventing relapse of glioma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728716.3A CN104491060A (en) | 2014-12-05 | 2014-12-05 | Tradtional Chinese medicine for preventing relapse of glioma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491060A true CN104491060A (en) | 2015-04-08 |
Family
ID=52932574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410728716.3A Pending CN104491060A (en) | 2014-12-05 | 2014-12-05 | Tradtional Chinese medicine for preventing relapse of glioma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491060A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105012745A (en) * | 2015-07-30 | 2015-11-04 | 武志鹏 | Drug for postoperative recovery of brain glioma |
CN106822844A (en) * | 2017-03-16 | 2017-06-13 | 河南中医药大学 | A kind of Chinese medicine composition of prevention glioma postoperative recurrence |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579677A (en) * | 2012-04-08 | 2012-07-18 | 许从玉 | Chinese medicinal composition for treating brain glioma |
CN103251880A (en) * | 2013-03-08 | 2013-08-21 | 翁捷 | Pharmaceutical composition for treating tumor and preparation method thereof |
CN103520360A (en) * | 2013-10-16 | 2014-01-22 | 中国海洋大学 | Chinese herbal compound preparation, and preparation method and application of Chinese herbal compound preparation |
-
2014
- 2014-12-05 CN CN201410728716.3A patent/CN104491060A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579677A (en) * | 2012-04-08 | 2012-07-18 | 许从玉 | Chinese medicinal composition for treating brain glioma |
CN103251880A (en) * | 2013-03-08 | 2013-08-21 | 翁捷 | Pharmaceutical composition for treating tumor and preparation method thereof |
CN103520360A (en) * | 2013-10-16 | 2014-01-22 | 中国海洋大学 | Chinese herbal compound preparation, and preparation method and application of Chinese herbal compound preparation |
Non-Patent Citations (4)
Title |
---|
周洁等: "脑瘤散治疗复发性脑胶质瘤的临床研究", 《天津中医药》 * |
杜德元: "中医论治肿瘤的研究进展", 《辽宁中医杂志》 * |
杨锋等: "康得方抗肿瘤作用的实验研究", 《中国中医药科技》 * |
王岩: "三芪抗瘤汤治疗脑胶质瘤术后60 例临床观察", 《河北中医药学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105012745A (en) * | 2015-07-30 | 2015-11-04 | 武志鹏 | Drug for postoperative recovery of brain glioma |
CN106822844A (en) * | 2017-03-16 | 2017-06-13 | 河南中医药大学 | A kind of Chinese medicine composition of prevention glioma postoperative recurrence |
CN113967244A (en) * | 2017-03-16 | 2022-01-25 | 河南中医药大学 | Traditional Chinese medicine composition and medicine for preventing postoperative recurrence of glioma, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100417403C (en) | Traditional Chinese medicine for treating cancer | |
CN103071093B (en) | Medicine for treating gynecological diseases | |
CN100556446C (en) | The Chinese medicine of treatment hepatocarcinoma | |
CN104606352A (en) | Bone tuberculosis treating compound pill | |
CN103861046A (en) | Traditional Chinese medicine for treating prosopalgia | |
CN105343724A (en) | Traditional Chinese medicine composition for treating gynecological diseases | |
CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
CN103656365B (en) | A kind of Chinese medicine for the treatment of the hyperthyroidism of deficiency of YIN of both the heart and liver pattern of syndrome | |
CN104491060A (en) | Tradtional Chinese medicine for preventing relapse of glioma | |
CN107412640B (en) | External ointment for assisting acupuncture and moxibustion physiotherapy | |
CN104491775A (en) | Tradtional Chinese medicament for treating post cerebral hemorrhage depressions | |
CN102266435B (en) | Traditional Chinese medicine for treating psoriasis | |
CN103920046A (en) | Medicine for treating cystitis and preparation method thereof | |
CN103417788B (en) | One treats fracture Chinese medicine for oral administration | |
CN102579607B (en) | Chinese medicine composition for treating acne | |
CN105194572A (en) | Traditional Chinese medicine composition for treating gliomas | |
CN101647981B (en) | Drug for treating blood-deficiency and wind-dry type psoriasis | |
CN104383453A (en) | Traditional Chinese medicine for treating mania caused by traumatic brain injury | |
CN103041085A (en) | Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application | |
CN101869629B (en) | Traditional Chinese medicine for treating renal calculus | |
CN104383417A (en) | Medicine for curing breast cancer | |
CN105287798A (en) | Lipid-lowering and slimming recovery pill | |
CN105194588A (en) | Traditional Chinese medicine preparation for treating liver cirrhosis | |
CN104645233A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
CN104587297A (en) | Traditional Chinese medicine capsule for treating scleroderma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |